Risk of postdischarge infection with vancomycin-resistant enterococcus after initial infection or colonization

Infect Control Hosp Epidemiol. 2010 Dec;31(12):1290-3. doi: 10.1086/657332. Epub 2010 Oct 27.

Abstract

Postdischarge risks of vancomycin-resistant Enterococcus (VRE) infection among carriers are unknown. We conducted a retrospective cohort study of 199 patients newly detected as VRE carriers. Fifteen patients (8%) developed 27 VRE infections in the 18 months after detection. Among 10 postdischarge infections, 2 involved bacteremia and 3 resulted in readmission.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Academic Medical Centers
  • Aged
  • Aged, 80 and over
  • Bacteremia / epidemiology*
  • Boston / epidemiology
  • Cross Infection / epidemiology*
  • Cross Infection / microbiology*
  • Enterococcus
  • Female
  • Humans
  • Male
  • Patient Discharge
  • Population Surveillance
  • Retrospective Studies
  • Risk Factors
  • Treatment Outcome
  • Vancomycin Resistance